Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1714-1715, 2004; 10.1373/clinchem.2004.034769
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, A.
Right arrow Articles by Maisel, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, A.
Right arrow Articles by Maisel, A. S.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2004;50:1714-1715.)
© 2004 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Evolving Use of B-Type Natriuretic Peptide in Clinical Practice

Alex Harrison, Vikas Bhalla, Nancy Gardetto and Alan S. Maisela

1 Division of Cardiology, Department of Medicine, Veteran’s Affairs Medical Center and University of California, San Diego, CA

aAddress correspondence to this author at: VAMC Cardiology 111-A, 3350 La Jolla Village Dr., San Diego, CA 92161. Fax 858-552-7490; e-mail amaisel@ucsd.edu.

The first 20% of the full text of this article appears below.


To the Editor:

Point-of-care B-natriuretic peptide (BNP) assays have become an accepted part of the diagnostic armamentarium for the physician attending to acutely dyspneic patients (1). The present study was done to analyze the evolving use of BNP measurements in a variety of settings at the San Diego Veteran’s Affairs (VA) Hospital, the first US institution to implement the commercialized Triage BNP Assay (2).

The study was approved by the Institutional Review Board. An analysis of the total number of BNP assays and the departments from which the assays were ordered was performed on all BNP measurements performed at the San Diego VA Hospital during the months of January through March of 2001, 2002, and 2003. Because we compared the use of BNP testing in the same quarter of the year over the 3 consecutive years, we believed it would effectively show the trends in BNP assay use.

During the period January through March of 2001, there . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.